All In Biotech

Free tool

FAERS Monitor: Flarex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019079 or its brand name (Flarex, Fluorometholone Acetate). Reports on generic versions are filed under their own applications.

Reports

267

Serious

102

38% of reports

Hospitalization

39

Death reported

8

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • eye pain64
  • eye irritation30
  • drug ineffective22
  • vision blurred21
  • headache19
  • off label use19
  • product dose omission issue19
  • ocular hyperaemia18
  • photophobia16
  • fatigue15
  • dizziness12
  • diarrhoea11
  • pain11
  • wrong technique in product usage process11
  • intraocular pressure increased10

Reports by year received

View as table
YearReports
20043
200610
20083
20105
20113
20123
20132
20146
20154
201612
20179
201812
20199
202018
202123
202231
202358
202429
202519
20268

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,892 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eye painSignal6489.572.25,519
photophobiaSignal1667.141.7976
intraocular pressure increasedSignal1061.733.6538
eye irritationSignal3041.129.31,136
ocular hyperaemiaSignal1829.919.1475
vision blurredSignal2112.08.0203
product dose omission issueSignal195.13.359
wrong technique in product usage processSignal114.32.425
headacheSignal192.41.514
dizziness121.91.14
off label use191.71.15
fatigue151.50.92
pain111.40.81
diarrhoea111.30.81
drug ineffective221.30.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.